Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Resverlogix's RVX-297 shows promise in model of multiple sclerosis

July 6, 2011

Preclinical and clinical phase I and II data reported on antidiabetes agent MK-0893

July 6, 2011

Preclinical and phase I data show LY-2409021 lowers glucose

July 6, 2011

AR-00472159 has anti-inflammatory activity in mice with experimental colitis

July 5, 2011

Cannabinoid CB1 receptor inverse agonist JD-5037 has no effects on CNS

July 5, 2011

AN-6414 is safe and improves symptoms of arthritis in preclinical studies

July 5, 2011

Zealand Pharma presents new preclinical data on ZP-3022 and ZP-2929 in models of diabetes/obesity

July 5, 2011

SRT-2104 exhibits anti-inflammatory activity in model of colitis

July 4, 2011

PAI-1 inhibitors TM-5275 and TM-5441 show promise to treat diabetic nephropathy

July 4, 2011

Phase II data presented on CCX-140-B in type 2 diabetes

July 4, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...